Skip to content

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Enhancing the Implementation of Tobacco Treatment: A Community-responsive Approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06837220
Enrollment
24
Registered
2025-02-20
Start date
2026-07-20
Completion date
2027-05-01
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Use Disorder, Smoking Cessation, Smoking Cessation Intervention

Keywords

smoking, smoking cessation, nicotine, nicotine use disorder, quitting smoking, quitting nicotine, respiratory health, telehealth, virtual, tobacco, tobacco treatment, community, behavioral health, chicago, group therapy, disparities, adults who smoke, cigarettes, tobacco cessation, cessation, abstinence, substance use, substance abuse, addiction, counseling, health counseling, health communication

Brief summary

The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, treatment programs and adults who smoke (AWS) in Chicago. This will be accomplished by establishing a community advisory board (CAB) and pilot testing a community-informed smoking cessation treatment within a community behavioral health organization to determine its feasibility after addressing implementation issues.

Detailed description

The purpose of the proposed study is to determine barriers and unmet smoking cessation treatment needs from leaders in behavioral health organizations, behavioral health treatment providers, and community members in Chicago and pilot test a community-informed, targeted rolling smoking cessation treatment within a community organization. The research team and the Respiratory Health Association (RHA) will work together to identify community sites that could derive possible benefit from adopting and implementing the targeted treatment. Aim 1: Develop a Community Advisory Board (CAB) comprised of providers, community members, and organization leadership. Aim 2: Use a mixed-methods approach to understand barriers, facilitators, and unmet treatment needs regarding smoking cessation treatment within the community. Aim 3: Pilot test the targeted smoking cessation treatment across a 3-month period at one community site through partnership with Respiratory Health Association. Hypothesis: The targeted intervention will demonstrate feasibility and acceptability.

Interventions

BEHAVIORALEnhanced Courage to Quit

Participants will engage in a version of the smoking cessation treatment "Courage to Quit" that has been optimized for implementation in community behavioral health clinics. The group will run over a period of 3 months, where participants will learn behavioral and cognitive skills for smoking cessation and/or reduction. Special attention will be given to the unique needs of the community, such as technology options or more flexible treatment models. The goal of this intervention is to prove that it is feasible to implement, and can create enhanced engagement and smoking outcomes for adults who smoke (AWS) and have fewer socioeconomic resources.

Sponsors

University of Chicago
Lead SponsorOTHER
Respiratory Health Association
CollaboratorUNKNOWN
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years
Healthy volunteers
No

Inclusion criteria

* Identify as someone who currently smokes combustible cigarettes (at least 1 cigarette per day) on each day for the past month * Report interest in quitting cigarettes (at least 6/10 scale in interest of quitting) * Age 18 or older, ability to understand the English language, willing and able to provide informed consent * Stable residence and contact information throughout the follow up period

Exclusion criteria

* Non-daily or intermittent cigarette use * No interest in quitting smoking * Unstable residence/not staying in Chicago for duration of study period * Current untreated severe substance use disorder (with the exception of tobacco use) or past-year serious untreated psychiatric illness (e.g. schizophrenia, bipolar disorder, obsessive compulsive disorder, unspecified psychosis, past-year suicide attempt)

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who attend the enhanced intervention as assessed by enrollment and sign-in at each session3 monthsInvestigators will consider the initial pilot period of the enhanced intervention successful if the team enrolls (attend one session) and retains (attend four or more sessions) at least three participants in the pilot treatment across three months
Feasibility will be assessed by calculating the portion of people who enroll (attend at least on session) and complete 4+ sessions versus those who drop out before finishing 4 sessions as assessed by session sign-in3 monthsInvestigators will consider the intervention design to be feasible if fewer than 40% of enrollees drop out after their first attended session.
A modified version of the Client Satisfaction Questionnaire (CSQ) will assess intervention acceptability.End of treatment (e.g., 3 months or fourth session attended, whichever comes first)This measure is a 10-point Likert scale (0=not at all, 10=very much) that assesses items such as intervention quality, effectiveness, and intrusiveness. For acceptability, the study team predicts at least 75% of participants will rate the intervention as acceptable via post-treatment survey (CSQ).

Secondary

MeasureTime frameDescription
Change in number of cigarettes consumed per dayThrough study completion, an average of 3 monthsParticipant self-report of past week average cigarettes smoked per day
Use of nicotine replacement therapy and FDA-approved cessation medicationThrough study completion, an average of 3 monthsParticipant self-report of pharmacotherapy will be assessed at each session and end of treatment
Number of quit attemptsThrough study completion, an average of 3 monthsThe number of times each participant has tried to quit, whether successful or not
Motivation to change smoking behavior via Contemplation LadderThrough study completion, an average of 3 monthsParticipants' interest in quitting will be assessed on a 10-point quit interest scale (e.g., The Contemplation Ladder). Scores range from 0-10 with higher scores indicating greater motivation to change.

Countries

United States

Contacts

CONTACTEmma Brett, PhD
ebrett@bsd.uchicago.edu773-834-5341
CONTACTSophie Miller, BS
sophie.miller@bsd.uchicago.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026